EJC Skin Cancer (Jan 2024)

Comparative Analysis of Pembrolizumab Dosing Schedules in the Adjuvant Treatment of Malignant Melanoma

  • Y. Ahmed,
  • E. Finnegan,
  • H. Ibrahim,
  • D. Sabu

DOI
https://doi.org/10.1016/j.ejcskn.2024.100147
Journal volume & issue
Vol. 2
p. 100147

Abstract

Read online

No abstracts available.